Michelle Yeomans

I joined the Inspectorate in 2005 and have worked across the GXP teams as an Inspector, Senior Inspector and GMDP Operations Manager. In October 2017, I took on a full time project based role focusing on business process improvement and to lead the Inspectorate inputs to the Agency's Operational Transformation Programme and Digital Transformation projects going forward.

GMP Inspectorate: blood compliance report assessment process

Michelle Yeomans, 4 August 2015 - Compliance matters, Good manufacturing practice

The good manufacturing practice (GMP) Inspectorate performs a varied role in ensuring both medicines and bloods are available and are of the right quality using a risk-based inspection programme. A programme for the inspection of manufacturer and wholesale dealer licence …

About the MHRA Inspectorate Blog

This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.

Find out more

Categories

Follow us on social media

• MHRA Twitter
• MHRA Medicines Twitter
• LinkedIn company page

Sign up and manage updates

• Email
• Atom

Printing Posts

You can print blog posts using the keyboard shortcuts "Control P" or "Command P".

Other MHRA Blogs

MedRegs

Comments and moderation

Read our guidelines

Recent posts

• MHRA Good Clinical and Laboratory Practice Symposia (11 and 12 February 2025)
• Public Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2
• DSUR Submissions and Fees are Changing from 1 June 2024
• Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium
• Pilot GMP Single Inspection Program